Board of directors

David Agus, M.D., Navigenics Co-founder

Dr. David Agus is a Professor of Medicine at the University of Southern California and Director of the USC Center for Applied Molecular Medicine and the USC Westside Prostate Cancer Center. In addition to co-founding Navigenics, Dr. Agus also founded Oncology.com, the largest cancer internet resource/community. More

Mari Baker, Navigenics' founding President and CEO

Mari Baker was the founding President and CEO of Navigenics. Under her leadership, the company became the #1 physician-recommended personal genomics company providing medically relevant genetic predisposition information. In addition to serving as a Navigenics board member, Ms. Baker is currently the CEO of PlayFirst Inc. More

David Brailer, M.D., Ph.D., Chairman, Health Evolution Partners

David Brailer was the first national coordinator for health information technology, appointed by President Bush in 2004. More recently, Dr. Brailer founded Health Evolution Partners, a private equity fund focused on transforming the health-care industry through greater efficiency, quality and responsiveness to consumers. More

Brook Byers (observer), Partner, Kleiner Perkins Caufield & Byers

Brook Byers has been a venture capital investor since 1972. He formed the first Life Sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare, and biotechnology sectors. He is currently on the Board of Directors of ten companies, most recently joining CardioDX, Genomic Health Incorporated and Pacific Biosciences. More

John Doerr, Partner, Kleiner Perkins Caufield & Byers

John Doerr has backed many of America's best entrepreneurial leaders. He came to Silicon Valley in 1974 and joined a small chip maker, Intel, just as it launched the legendary 8080 microprocessor. He serves on the boards of Google, Amazon, Intuit, Homestore and Sun. More

Mark Kvamme (observer), Partner, Sequoia Capital

Mark Kvamme focuses on investments in software and services. Prior to joining Sequoia Capital in 1999, he was chairman of USWeb/CKS. More

Dana G. Mead, Jr., Partner, Kleiner Perkins Caufield & Byers

Dana G. Mead has focused on identifying new medical technologies, developing new markets and therapies and building world-class management teams. Prior to joining KPCB, Mr. Mead was president of Guidant Vascular Intervention. More

Sue Siegel, Partner, MDV-Mohr Davidow Ventures

Sue Siegel has spent more than two decades commercializing key enabling technologies in biomedical research and health care. Prior to joining MDV, Ms. Siegel was president and director of Affymetrix, a company that helped propel the expansion of the genomics field and the opportunity for personalized medicine. More

Dietrich Stephan, Ph.D., (observer), Navigenics Co-founder and Chief Science Officer

Dietrich Stephan is a human geneticist on the faculty of the Translational Genomics Research Institute and chairman of the National Institutes of Health Neuroscience Microarray Consortium. He has identified genes that predispose to disorders such as autism, exercise-induced heart attacks and sudden infant death syndrome, and contributed to understanding a multitude of common disorders such as Alzheimer's disease. More